KNSA Insider Trading

Insider Ownership Percentage: 54.57%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,107,784.93

Kiniksa Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Kiniksa Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kiniksa Pharmaceuticals Share Price & Price History

Current Price: $20.59
Price Change: Price Increase of +0.1 (0.49%)
As of 12/20/2024 06:16 PM ET

This chart shows the closing price history over time for KNSA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Kiniksa Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2024Mark RagosaCFOSell1,123$21.25$23,863.7522,958View SEC Filing Icon  
12/3/2024Mark RagosaCFOSell8,969$21.45$192,385.0522,958View SEC Filing Icon  
10/15/2024Eben TessariCOOSell17,000$26.87$456,790.00109,975View SEC Filing Icon  
9/23/2024Eben TessariCOOSell17,500$24.99$437,325.00116,975View SEC Filing Icon  
9/3/2024John F PaoliniInsiderSell60,692$26.12$1,585,275.0452,038View SEC Filing Icon  
8/27/2024Eben TessariCOOSell17,500$26.91$470,925.00119,911View SEC Filing Icon  
7/23/2024John F PaoliniInsiderSell22,000$26.32$579,040.0047,803View SEC Filing Icon  
7/23/2024Mark RagosaCFOSell24,248$24.79$601,107.9219,253View SEC Filing Icon  
7/23/2024Sanj K PatelCEOSell136,124$25.65$3,491,580.6063,012View SEC Filing Icon  
3/6/2024Sanj K PatelCEOSell5,582$21.00$117,222.0065,012View SEC Filing Icon  
3/4/2024Sanj K PatelCEOSell12,742$21.49$273,825.5870,594View SEC Filing Icon  
3/1/2024Michael R MegnaCAOSell9,659$21.45$207,185.5517,588View SEC Filing Icon  
2/28/2024Michael R MegnaCAOSell5,126$21.79$111,695.5417,588View SEC Filing Icon  
1/3/2024Mark RagosaCFOSell12,000$20.00$240,000.0015,632View SEC Filing Icon  
1/2/2024Michael R MegnaCAOSell16,670$19.17$319,563.9017,005View SEC Filing Icon  
12/19/2023Michael R MegnaCAOSell9,316$19.13$178,215.0817,005View SEC Filing Icon  
12/7/2023John F PaoliniInsiderSell28,600$17.65$504,790.0044,892View SEC Filing Icon  
9/5/2023John F PaoliniInsiderSell400$17.53$7,012.0044,892View SEC Filing Icon  
7/25/2023John F PaoliniInsiderSell29,000$19.14$555,060.0041,910View SEC Filing Icon  
11/29/2022Barry D. QuartDirectorSell21,959$16.15$354,637.85View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

53.95% of Kiniksa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KNSA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Kiniksa Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/19/2024Principal Financial Group Inc.52,851$1.32M0.0%-21.1%0.073%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.67,533$1.80M0.0%+1.7%0.094%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC482,976$12.07M0.0%-43.1%0.669%Search for SEC Filing on Google Icon
11/15/2024M&T Bank Corp30,735$0.77M0.0%-15.5%0.043%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd27,302$0.68M0.0%+62.2%0.038%Search for SEC Filing on Google Icon
11/15/2024Castleark Management LLC167,200$4.18M0.2%N/A0.232%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC345,092$8.62M0.0%+1,064.4%0.478%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP47,717$1.19M0.0%N/A0.066%Search for SEC Filing on Google Icon
11/15/2024State Street Corp704,712$17.61M0.0%-50.3%0.976%Search for SEC Filing on Google Icon
11/15/2024Quarry LP2,000$50K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC755,244$18.87M2.4%+16.7%1.046%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC74,639$1.87M0.6%-15.8%0.103%Search for SEC Filing on Google Icon
11/15/2024ArrowMark Colorado Holdings LLC531,286$13.28M0.2%-12.7%0.736%Search for SEC Filing on Google Icon
11/15/2024Paloma Partners Management Co19,300$0.48M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/14/2024Hhlr Advisors LTD.1,582,635$39.55M0.9%-49.7%2.192%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC37,242$0.93M0.1%N/A0.052%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP2,894,513$72.33M2.1%+40.6%4.009%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC26,784$0.67M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P48,460$1.21M0.0%+6.8%0.067%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC44,229$1.11M0.0%N/A0.061%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank7,553$0.19M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC21,721$0.54M0.0%+129.1%0.030%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets192,926$4.82M0.0%+121.7%0.267%Search for SEC Filing on Google Icon
11/13/2024FMR LLC696,810$17.41M0.0%+36,925.0%0.965%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP20,367$0.51M0.1%-34.8%0.028%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company14,175$0.35M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC26,124$0.65M0.0%-13.6%0.036%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC91,159$2.28M0.1%+390.0%0.126%Search for SEC Filing on Google Icon
11/12/2024Cerity Partners LLC33,384$0.83M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.89,626$2.24M0.0%-3.0%0.124%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA66,816$1.67M0.0%-2.4%0.093%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.324,064$8.10M0.0%+40.2%0.455%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC27,026$0.68M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.14,902$0.37M0.0%-14.1%0.021%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP10,729$0.27M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC100,001$2.50M0.0%+26.3%0.140%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.52,851$1.32M0.0%-21.1%0.074%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC11,478$0.29M0.2%N/A0.016%Search for SEC Filing on Google Icon
10/29/2024Harbor Capital Advisors Inc.97,543$2.44M0.1%N/A0.138%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC649,630$16.23M0.9%+8.2%0.916%Search for SEC Filing on Google Icon
10/25/2024AMI Asset Management Corp51,262$1.28M0.1%N/A0.072%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.7,810$0.20M0.0%+65.0%0.011%Search for SEC Filing on Google Icon
10/24/2024Semanteon Capital Management LP22,057$0.55M0.4%N/A0.031%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.195,852$4.89M0.2%+7.6%0.276%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC57,627$1.44M0.0%-11.3%0.081%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC3,200$80K0.0%N/A0.005%Search for SEC Filing on Google Icon
10/10/2024Essex Investment Management Co. LLC200,516$5.01M0.9%+0.4%0.283%Search for SEC Filing on Google Icon
10/8/2024CWM LLC2,449$61K0.0%+443.0%0.003%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC18,603$0.35M0.0%+78.1%0.026%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC615,836$11.50M0.1%-1.1%0.868%Search for SEC Filing on Google Icon
8/15/2024Lion Point Capital LP104,691$1.96M3.6%-19.9%0.148%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP9,500$0.18M0.1%N/A0.013%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC621,948$11.61M0.0%+159.8%0.877%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC125,995$2.35M0.0%-20.9%0.178%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC24,845$0.46M0.0%+84.0%0.035%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC11,504$0.22M0.0%-47.8%0.016%Search for SEC Filing on Google Icon
8/13/2024Rubric Capital Management LP2,419,103$45.17M1.2%+10.2%3.410%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.38,976$0.73M0.0%-47.0%0.055%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd16,828$0.31M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/12/2024Mercer Global Advisors Inc. ADV16,590$0.31M0.0%-6.2%0.023%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP664,040$12.40M0.0%+31.2%0.936%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA68,434$1.28M0.0%-9.3%0.096%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.29,226$0.55M0.0%+33.4%0.041%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC600,630$11.21M0.7%-2.9%0.847%Search for SEC Filing on Google Icon
8/7/2024Ashton Thomas Private Wealth LLC5,361$100K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC57,230$1.07M0.0%-65.2%0.081%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC79,200$1.48M0.0%-43.4%0.112%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System11,192$0.21M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers56,066$1.05M0.0%-8.7%0.079%Search for SEC Filing on Google Icon
8/1/2024Hussman Strategic Advisors Inc.147,000$2.74M0.8%-6.7%0.207%Search for SEC Filing on Google Icon
7/29/2024Peregrine Capital Management LLC239,156$4.47M0.1%+1.3%0.337%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.66,951$1.25M0.0%+13.5%0.094%Search for SEC Filing on Google Icon
7/26/2024Allspring Global Investments Holdings LLC64,943$1.21M0.0%+6.3%0.092%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp115,143$2.15M0.0%+2.3%0.162%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.181,966$3.40M0.2%+45.7%0.257%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC69,226$1.29M0.0%+261.3%0.098%Search for SEC Filing on Google Icon
7/12/2024QRG Capital Management Inc.14,033$0.26M0.0%-7.5%0.020%Search for SEC Filing on Google Icon
7/10/2024Linden Thomas Advisory Services LLC118,302$2.21M0.3%+1.7%0.167%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System28,662$0.57M0.0%-5.4%0.040%Search for SEC Filing on Google Icon
5/16/2024Bayesian Capital Management LP11,245$0.22M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC3,607$71K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/15/2024Hhlr Advisors LTD.3,135,735$61.87M1.3%N/A4.420%Search for SEC Filing on Google Icon
5/15/2024Altitude Crest Partners Inc.400,441$7.90M3.4%-12.2%0.564%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC164,568$3.24M0.0%+167.8%0.232%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,981,894$58.83M0.0%+0.6%4.203%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System13,467$0.27M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/8/2024QRG Capital Management Inc.15,178$0.30M0.0%-5.2%0.021%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.73,481$1.45M0.0%N/A0.104%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC19,160$0.38M0.0%+8.1%0.027%Search for SEC Filing on Google Icon
5/3/2024Essex Investment Management Co. LLC172,740$3.41M0.7%+0.5%0.245%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB126,742$2.49M0.0%N/A0.179%Search for SEC Filing on Google Icon
5/2/2024Hussman Strategic Advisors Inc.157,500$3.11M0.7%N/A0.223%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC26,843$0.53M0.0%+7.8%0.038%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets46,060$0.91M0.0%-39.9%0.065%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.20,935$0.41M0.0%+5.8%0.030%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.58,991$1.16M0.0%+42.7%0.084%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.7,708$0.15M0.0%+88.1%0.011%Search for SEC Filing on Google Icon
4/26/2024Peregrine Capital Management LLC236,045$4.66M0.1%N/A0.334%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC618,798$12.21M0.7%-2.7%0.876%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC61,106$1.21M0.0%+18.4%0.087%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Kiniksa Pharmaceuticals logo
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was incorporated in 2015 and is based in Hamilton, Bermuda.
Read More on Kiniksa Pharmaceuticals

Today's Range

Now: $20.59
Low: $20.20
High: $20.69

50 Day Range

MA: $22.79
Low: $20.06
High: $27.59

52 Week Range

Now: $20.59
Low: $16.56
High: $28.15

Volume

592,646 shs

Average Volume

397,777 shs

Market Capitalization

$1.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals' top insider shareholders include:
  1. Eben Tessari (COO)
  2. Sanj K Patel (CEO)
  3. John F Paolini (Insider)
  4. Mark Ragosa (CFO)
  5. Michael R Megna (CAO)
Learn More about top insider investors at Kiniksa Pharmaceuticals.

Who are the major institutional investors of Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals' top institutional shareholders include:
  1. Braidwell LP — 4.01%
  2. Hhlr Advisors LTD. — 2.19%
  3. Parkman Healthcare Partners LLC — 1.05%
  4. State Street Corp — 0.98%
  5. FMR LLC — 0.97%
  6. Rice Hall James & Associates LLC — 0.92%
Learn More about top institutional investors of Kiniksa Pharmaceuticals stock.

Which major investors are selling Kiniksa Pharmaceuticals stock?

During the last quarter, KNSA stock was sold by these institutional investors:
  1. Hhlr Advisors LTD.
  2. State Street Corp
  3. Geode Capital Management LLC
  4. ArrowMark Colorado Holdings LLC
  5. Principal Financial Group Inc.
  6. Principal Financial Group Inc.
  7. HighVista Strategies LLC
  8. Advantage Alpha Capital Partners LP
During the previous year, company insiders that have sold Kiniksa Pharmaceuticals company stock include:
  1. Eben Tessari (COO)
  2. Sanj K Patel (CEO)
  3. John F Paolini (Insider)
  4. Mark Ragosa (CFO)
  5. Michael R Megna (CAO)
Learn More investors selling Kiniksa Pharmaceuticals stock.

Which major investors are buying Kiniksa Pharmaceuticals stock?

In the previous quarter, KNSA stock was bought by institutional investors including:
  1. Braidwell LP
  2. FMR LLC
  3. Jane Street Group LLC
  4. Castleark Management LLC
  5. Parkman Healthcare Partners LLC
  6. BNP Paribas Financial Markets
  7. Harbor Capital Advisors Inc.
  8. Connor Clark & Lunn Investment Management Ltd.